COVID-19 rapid test
for neutralizing antibodySARS-COV-2serum

COVID-19 rapid test
COVID-19 rapid test
Add to favorites
Compare this product
 

Characteristics

Applications
COVID-19
Tested parameter
for neutralizing antibody
Micro-organism
SARS-COV-2
Sample type
serum, plasma
Analysis mode
immunofluorescence

Description

UNICELL-2019-nCoV NAb (Neutralization Antibody) assay is a Fluorescent Immunoassays (FIA) for the quantitative determination of 2019-nCoV Neutralization Antibodies in human serum or plasma. This assay can simulate the in vivo binding of SARS-CoV-2 RBD to ACE2-receptor in human host cells after SARS-CoV-2 infection or vaccination. UNICELL-2019-nCoV NAb (Neutralization Antibody) assay is a Fluorescent Immunoassays (FIA) for the quantitative determination of 2019-nCoV Neutralization Antibodies in human serum or plasma. This assay can simulate the in vivo binding of SARS-CoV-2 RBD to ACE2-receptor in human host cells after SARS-CoV-2 infection or vaccination. Features: ●Convenient: Easy operation with minimal maintainence required ●Automation: Perform Neutralization Antibody test on a standardized POCT platform ●Testing Flexibility: Flexible testing capacity, first result within 15 minutes,3 different test modes

Catalogs

No catalogs are available for this product.

See all of Shenzhen Yhlo Biotech Co., Ltd.‘s catalogs
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.